Rick Helmich, researcher at the Donders Center for Medical Neurosciences, receives a grant of $ 693,000 from the Michael J Fox Foundation. With this he can investigate the brain mechanisms that are responsible for the progression of Parkinson's disease. In theresearch He uses the data collected in the Personalized Parkinson Project.The grant of 693,000 dollarwill be used to investigate the cerebral mechanisms underlying disease progression in Parkinson's disease. Rick Helmich and his team will test the hypothesis that disease progression is mainly caused by a collapse of compensatory mechanisms.
To this end, they will make use of the data from the Personalized Parkinson Project (led by Bas Bloem), which is a longitudinal study in 650 Parkinson patients who will receive brain scans at baseline and after a followup of 2 years.). For the project, they will use half of this population (n=325), who will perform a motor task in the fMRI scanner at both time points. The task is optimized to detect dysfunctional activity in the basal ganglia, and compensatory activity in cortical regions (parietal cortex). They will relate changes in activity on both regions to clinical disease progression.
If they show that disease progression is mainly caused by changes in compensatory activity (rather than dysfunctional activity in the basal ganglia), then this may shift the treatment focus from cells that are gone (dopamine depletion) to cells that survive (compensation).
Related news items
Roel op 't Veld wins Young Investigator Award at ETRS congress 201725 September 2017
With his oral presentation titled 'Thermosensitive biomimetic polyisocyanopeptide hydrogels may facilitate wound repair'.read more
How to measure >70 (phospho-) protein levels via sequencing DNA-tagged antibodies21 June 2018
Jessie van Buggenum and Klaas Mulder, theme Cancer development and immune defense, show in Nature Communications how immuno-detection by sequencing uses antibodies tagged with DNA barcodes and high-throughput sequencing to detect up to 70 phospho-proteins in skin stem cell.read more
Gelderland and Radboudumc combine their innovative strengths New cooperation agenda between the Province of Gelderland and Radboud university medical center16 March 2018
Gelderland aims to become the leading international testing ground for medical innovations by 2030. To achieve this, the Province of Gelderland and Radboud university medical center drafted a joint cooperation agenda.read more